An oral drug improved wakefulness and cataplexy in narcolepsy trials
Two randomized phase 3 trials found that the oral drug oveporexton improved wakefulness, daytime sleepiness and cataplexy in people with narcolepsy type 1. Increased urinary frequency and temporary insomnia were common among participants who received the drug.
·112 views